168 related articles for article (PubMed ID: 35478691)
21. [PET/CT Image Values in Clinical Staging of the Patients with Non-Hodgkin's Lymphoma].
Tang HJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1030-3. PubMed ID: 26314440
[TBL] [Abstract][Full Text] [Related]
22. Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group.
Cerci JJ; Bogoni M; Buccheri V; Etchebehere ECSC; Silveira TMBD; Baiocchi O; Neto CACP; Sapienza MT; Marin JFG; Meneghetti JC; Novis Y; Souza CA; Chiattone C; Torresan M; Ramos CD
Hematol Transfus Cell Ther; 2018; 40(3):245-249. PubMed ID: 30128433
[TBL] [Abstract][Full Text] [Related]
23. 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma.
Shelly MJ; McDermott S; O'Connor OJ; Blake MA
ISRN Hematol; 2012; 2012():456706. PubMed ID: 22474590
[TBL] [Abstract][Full Text] [Related]
24. Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?
Reinhardt MJ; Herkel C; Altehoefer C; Finke J; Moser E
Ann Oncol; 2005 Sep; 16(9):1524-9. PubMed ID: 15946979
[TBL] [Abstract][Full Text] [Related]
25. Isolated Splenic Tuberculosis Masquerading as Disease Progression of Hodgkin's Lymphoma on Interim
Dey S; Gupta N; Verma R; Seniaray N; Belho ES; Dhawan S
Indian J Nucl Med; 2021; 36(1):100-102. PubMed ID: 34040315
[No Abstract] [Full Text] [Related]
26. Current role of FDG PET/CT in lymphoma.
Kostakoglu L; Cheson BD
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):1004-27. PubMed ID: 24519556
[TBL] [Abstract][Full Text] [Related]
27. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
[TBL] [Abstract][Full Text] [Related]
28. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U
Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
[TBL] [Abstract][Full Text] [Related]
29. Extensive Extranodal Involvement in a case of Non-Hodgkin's Lymphoma with sparing of lymph nodes and lymphatic organs.
Singh V; Kumar A; Singh P; Ora M; Gambhir S
Asia Ocean J Nucl Med Biol; 2021; 9(1):39-44. PubMed ID: 33392348
[TBL] [Abstract][Full Text] [Related]
30. Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma?
Fuster D; Chiang S; Andreadis C; Guan L; Zhuang H; Schuster S; Alavi A
Nucl Med Commun; 2006 Jan; 27(1):11-5. PubMed ID: 16340718
[TBL] [Abstract][Full Text] [Related]
31. F-18 Fluorodeoxyglucose Positron-Emission Tomography-Computed Tomography in a Case of Extensive Multi-Organal Extranodal Lymphoma with Cardiac Involvement Mimicking Apical Hypertrophic Obstructive Cardiomyopathy: Staging and Response Evaluation.
Vadi SK; Parihar AS; Mittal BR; Kumar R; Singh H; Malhotra P
Indian J Nucl Med; 2018; 33(4):370-373. PubMed ID: 30386069
[TBL] [Abstract][Full Text] [Related]
32. Whole-body MRI versus an [
Spijkers S; Littooij AS; Kwee TC; Tolboom N; Beishuizen A; Bruin MCA; Enríquez G; Sábado C; Miller E; Granata C; de Lange C; Verzegnassi F; de Keizer B; Nievelstein RAJ
Eur Radiol; 2021 Dec; 31(12):8925-8936. PubMed ID: 34021390
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K
World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888
[TBL] [Abstract][Full Text] [Related]
34. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
35. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
Mittal BR; Manohar K; Malhotra P; Das R; Kashyap R; Bhattacharya A; Varma N; Varma S
Leuk Lymphoma; 2011 Nov; 52(11):2111-6. PubMed ID: 21745169
[TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
Najjar F; Hustinx R; Jerusalem G; Fillet G; Rigo P
Cancer Biother Radiopharm; 2001 Aug; 16(4):297-304. PubMed ID: 11603000
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
Spaepen K; Stroobants S; Dupont P; Van Steenweghen S; Thomas J; Vandenberghe P; Vanuytsel L; Bormans G; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G
J Clin Oncol; 2001 Jan; 19(2):414-9. PubMed ID: 11208833
[TBL] [Abstract][Full Text] [Related]
39. Extensive Extranodal Involvement of Rare Sites in Non Hodgkin's Lymphoma Detected on (18)F- FDG PET-CT: A Case Report.
Dhull VS; Sharma P; Singla S; Faizi NA; Thulkar S; Bal C; Kumar R
Nucl Med Mol Imaging; 2013 Jun; 47(2):125-9. PubMed ID: 24900093
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of
Öner AO; Sürer Budak E; Aydın F; Salim O; Yücel OK; Akkaya B; Toptaş T; Boz A; Yıldız A; Güngör F; Undar L
Mol Imaging Radionucl Ther; 2017 Jun; 26(2):69-75. PubMed ID: 28613199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]